• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. NOVASURE IMPEDANCE CONTROLLED EA SYSTEM; UTERINE ABLATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. NOVASURE IMPEDANCE CONTROLLED EA SYSTEM; UTERINE ABLATION DEVICE Back to Search Results
Model Number NS2000
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Uterine Perforation (2121)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device history record (dhr) review was conducted for the identified lot number and serial number of the disposable device.No abnormalities were found related to the reported information.This device passed final testing prior to release.According to the instructions for use (ifu).Warnings: · use caution not to perforate the uterine wall when sounding, dilating, or inserting the disposable device.· if the disposable device is difficult to insert into the cervical canal, use clinical judgment to determine whether or not further dilation is required.· the novasure system performs a cavity integrity assessment (cia) test to evaluate the integrity of the uterine cavity, and sounds an alarm warning of a possible perforation prior to treatment.Reference internal complaint (b)(4).
 
Event or Problem Description
Note: this report pertains to the first of two hologic devices used in the same procedure.See associated medwatch, manufacturer's report# 1222780-2017-00260.It was reported the physician attempted a novasure endometrial ablation on (b)(6) 2017, and received several unsuccessful cavity integrity assessment (cia) tests using two disposable devices.The doctor performed a laparoscopy and visualized a perforation.No intervention was required and the patient was discharged home.A hysteroscopy, dilatation and curettage (d&c), and sounding with a metal sound (not hologic devices) were performed prior to the attempted ablation.It is not known when this perforation occurred or what instrument may have been the cause.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVASURE IMPEDANCE CONTROLLED EA SYSTEM
Common Device Name
UTERINE ABLATION DEVICE
Manufacturer (Section D)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
MDR Report Key6980722
Report Number1222780-2017-00258
Device Sequence Number156178
Product Code MNB
UDI-Device Identifier45420045501134
UDI-Public(01)45420045501134(10)17F28RH
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
P010013
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date07/28/2018
Device Model NumberNS2000
Device Catalogue Number915002-01
Device Lot Number17F28RH
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/19/2017
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/29/2017
Initial Report FDA Received Date10/26/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
RADIO FREQUENCY CONTROLLER: SERIAL# UNKNOWN
Outcome Attributed to Adverse Event Other;
-
-